Telehealth and online safety red flags As demand for weight-loss medications grows, the FDA is urging consumers to be cautious of telehealth platforms and online sellers that may be distributing unsafe or fraudulent products
Diabetes Obes Metab 15(1):1527 Nauck MA, DAlessio DA (2022) Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction
Preclinical and clinical studies suggest potential effects on bone metabolism, with evidence that GLP-1 receptor activation may support bone formation and remodeling
Verheijen, M
His new book, The 30-Day Inflammatory Reset , offers a practical, science-based roadmap to identify and eliminate hidden inflammationthe root cause of chronic health issuesthrough diet, lifestyle changes, and environmental modifications that will help you reclaim your energy, clarity, and vitality in just thirty days